Graham Capital Management’s Health Catalyst HCAT Stock Holding History

Graham Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,098	Closed	-$28.8K	–	1377
2025 Q3	$28.8K	Buy	+10,098	New	+$34.6K	﹤0.01%	1205
2025 Q2	–	Sell	-103,401	Closed	-$468K	–	1412
2025 Q1	$468K	Buy	103,401 +52,070	+101%	+$276K	0.01%	841
2024 Q4	$363K	Buy	51,331 +30,668	+148%	+$244K	0.01%	853
2024 Q3	$168K	Sell	20,663 -4,167	-17%	-$30.1K	﹤0.01%	951
2024 Q2	$159K	Buy	24,830 +223	+0.9%	+$1.43K	﹤0.01%	891
2024 Q1	$185K	Buy	+24,607	New	+$225K	﹤0.01%	915
2022 Q4	–	Sell	-30,523	Closed	-$296K	–	1149
2022 Q3	$296K	Buy	30,523 +4,584	+18%	+$60.7K	0.01%	908
2022 Q2	$375K	Buy	+25,939	New	+$442K	0.02%	757

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CDC Financial Chicago, Illinois $157M AUM

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Graham Capital Management's HCAT Position: Q4 2025 in Review

Graham Capital Management sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 10,098 shares — an estimated $28.8K sold.

Graham Capital Management first reported a position in HCAT in Q2 2022 and held it in 8 quarters. The position peaked at $468K in Q1 2025. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

Graham Capital Management reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
Graham Capital Management sold 10,098 Health Catalyst shares in Q4 2025, an estimated $28.8K.
Graham Capital Management first reported a position in Health Catalyst in Q2 2022 and held it in 8 quarters.
Graham Capital Management's Health Catalyst position peaked at $468K in Q1 2025.
136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.